Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer

Abstract

The “seed and soil” concept has reformed paradigms for cancer treatment in the past decade. Accumulating evidence indicates that the intimate crosstalk between cancer cells and stromal cells plays a tremendous role in tumor progression. Cancer-associated fibroblasts (CAFs), the largest population of stroma cells, influence therapeutic effects through diverse mechanisms. Herein, we summarize the recent advances in the versatile functions of CAFs regarding their heterogeneity, and we mainly discuss the pro-tumorigenic functions of CAFs which promote tumorigenesis and confer therapeutic resistance to tumors. Targeting CAFs is emerging as one of the most appealing strategies in anticancer therapies. The endeavors to target or reprogram the specific subtypes of CAFs provide great cancer treatment opportunities, which may provide a better clinical benefit to cancer patients.

Keywords

Cancer-associated fibroblasts (CAFs) / heterogeneity / therapeutic resistance / CAFs targeting

References

[1] Calon A,Berenguer-Llergo A.Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.Nat Genet2015;47:320-9

[2] Guinney J,Wang X.The consensus molecular subtypes of colorectal cancer.Nat Med2015;21:1350-6 PMCID:PMC4636487

[3] Hosein AN,Maitra A.Pancreatic cancer stroma: an update on therapeutic targeting strategies.Nat Rev Gastroenterol Hepatol2020;17:487-505 PMCID:PMC8284850

[4] Costa A,Scholer-Dahirel A.Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.Cancer Cell2018;33:463-479.e10

[5] Sahai E,Cukierman E.A framework for advancing our understanding of cancer-associated fibroblasts.Nat Rev Cancer2020;20:174-86 PMCID:PMC7046529

[6] Kalluri R.The biology and function of fibroblasts in cancer.Nat Rev Cancer2016;16:582-98

[7] Fiori ME,Villanova L,Stassi G.Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.Mol Cancer2019;18:70 PMCID:PMC6441236

[8] Ping Q,Cheng X.Cancer-associated fibroblasts: overview, progress, challenges, and directions.Cancer Gene Ther2021;28:984-99

[9] Tang LY,Meng Z.Transforming growth factor-β (TGF-β) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway.J Biol Chem2017;292:4302-12 PMCID:PMC5354477

[10] Wu F,Liu J.Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.Signal Transduct Target Ther2021;6:218 PMCID:PMC8190181

[11] Goulet C, Bernard G, Tremblay S, Chabaud S, Bolduc S, Pouliot F. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFβ signaling.Mol Cancer Res2018;16:1196-204

[12] Chen X.Turning foes to friends: targeting cancer-associated fibroblasts.Nat Rev Drug Discov2019;18:99-115

[13] Xie Z,Ho C.Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.Gut2022;71:568-79

[14] Weber CE,Wai PY.Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.Oncogene2015;34:4821-33 PMCID:PMC4476970

[15] Mao X,Wang W.Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.Mol Cancer2021;20:131 PMCID:PMC8504100

[16] Biffi G.Diversity and biology of cancer-associated fibroblasts.Physiol Rev2021;101:147-76 PMCID:PMC7864232

[17] Öhlund D,Biffi G.Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.J Exp Med2017;214:579-96 PMCID:PMC5339682

[18] Chen Y,Kalluri R.Clinical and therapeutic relevance of cancer-associated fibroblasts.Nat Rev Clin Oncol2021;18:792-804 PMCID:PMC8791784

[19] Bhattacharjee S,Ravichandra A.Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts.J Clin Invest2021;131:146987 PMCID:PMC8159701

[20] Elyada E,Laise P.Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts.Cancer Discov2019;9:1102-23 PMCID:PMC6727976

[21] Rhim AD,Thomas DH.Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.Cancer Cell2014;25:735-47 PMCID:PMC4096698

[22] Lee JJ,Wang H.Stromal response to Hedgehog signaling restrains pancreatic cancer progression.Proc Natl Acad Sci USA2014;111:E3091-100 PMCID:PMC4121834

[23] Özdemir BC,Carstens JL.Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.Cancer Cell2014;25:719-34 PMCID:PMC4180632

[24] Zhong B,Huang X.Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.Cell Death Dis2021;13:16 PMCID:PMC8688517

[25] Biffi G,Spielman B.IL1-Induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma.Cancer Discov2019;9:282-301 PMCID:PMC6368881

[26] Saw PE,Song E.Targeting CAFs to overcome anticancer therapeutic resistance.Trends Cancer2022;8:527-55

[27] Fullár A,Oláh L.Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.BMC Cancer2015;15:256 PMCID:PMC4409756

[28] Munir H,Janowitz T.Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth.Nat Commun2021;12:683 PMCID:PMC7846803

[29] Olive KP,Davidson CJ.Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.Science2009;324:1457-61 PMCID:PMC2998180

[30] Lokeshwar VB,Jordan A.Targeting hyaluronic acid family for cancer chemoprevention and therapy. Hyaluronan signaling and turnover. Elsevier; 2014. pp. 35-65. PMCID:PMC4791948

[31] Li Q,Ni B.Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts.EBioMedicine2019;49:157-71 PMCID:PMC7113184

[32] Saatci O,Raza U.Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.Nat Commun2020;11:2416 PMCID:PMC7229173

[33] Poggio M,Pai CC.Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory.Cell2019;177:414-427.e13 PMCID:PMC6499401

[34] Su S,Yao H.CD10⁺GPR77⁺ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness.Cell2018;172:841-856.e16

[35] Tang YA,Bao Y.Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.Proc Natl Acad Sci USA2018;115:E5990-9 PMCID:PMC6042102

[36] Hu JL,Lan XL.CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.Mol Cancer2019;18:91 PMCID:PMC6503554

[37] Thuwajit C,Titone R,Isidoro C.The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: autophagy plays a role.Med Res Rev2018;38:1235-54 PMCID:PMC6032948

[38] Wang Y,Wang B.Cancer-associated fibroblasts promote irradiated cancer cell recovery through autophagy.EBioMedicine2017;17:45-56 PMCID:PMC5360585

[39] Pavlides S,Migneco G.The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism.Cell Cycle2010;9:3485-505 PMCID:PMC3047615

[40] Xi L,Liu S.Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion.J Extracell Vesicles2021;10:e12146 PMCID:PMC8452512

[41] Ferraresi A,Esposito A.How autophagy shapes the tumor microenvironment in ovarian cancer.Front Oncol2020;10:599915 PMCID:PMC7753622

[42] Straussman R,Shee K.Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.Nature2012;487:500-4 PMCID:PMC3711467

[43] Kaur A,Marchbank K.sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.Nature2016;532:250-4 PMCID:PMC4833579

[44] Zhang Z,Lee YS.Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer.Cancer Cell2020;38:279-296.e9 PMCID:PMC7472556

[45] Wang W,Xiao Q.Stromal induction of BRD4 phosphorylation results in chromatin remodeling and BET inhibitor resistance in colorectal cancer.Nat Commun2021;12:4441 PMCID:PMC8295257

[46] Garvey CM,Sanchez A.Anti-EGFR therapy induces EGF secretion by cancer-associated fibroblasts to confer colorectal cancer chemoresistance.Cancers2020;12:1393 PMCID:PMC7352975

[47] Shen Y,Lu J.Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer.Cancer Cell2020;37:800-817.e7

[48] Hupfer A,Koeniger A.Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche.Proc Natl Acad Sci USA2021;118:e2105367118 PMCID:PMC8501848

[49] Kobayashi H,Woods SL,Takahashi M.Cancer-associated fibroblasts in gastrointestinal cancer.Nat Rev Gastroenterol Hepatol2019;16:282-95

[50] Binnewies M,Kersten K.Understanding the tumor immune microenvironment (TIME) for effective therapy.Nat Med2018;24:541-50 PMCID:PMC5998822

[51] Sorokin L.The impact of the extracellular matrix on inflammation.Nat Rev Immunol2010;10:712-23

[52] Joyce JA.T cell exclusion, immune privilege, and the tumor microenvironment.Science2015;348:74-80

[53] Yang X,Shi Y.FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling.Cancer Res2016;76:4124-35

[54] Lo A,Scholler J.Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells.Cancer Res2015;75:2800-10 PMCID:PMC4506263

[55] Feig C,Kraman M.Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.Proc Natl Acad Sci USA2013;110:20212-7 PMCID:PMC3864274

[56] Garg B,Modi S.NFκB in pancreatic stellate cells reduces infiltration of tumors by cytotoxic T cells and killing of cancer cells, via up-regulation of CXCL12.Gastroenterology2018;155:880-891.e8 PMCID:PMC6679683

[57] Mace TA,Pitarresi JR.IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.Gut2018;67:320-32 PMCID:PMC5406266

[58] Huang H,Zhang Y.Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer.Cancer Cell2022;40:656-673.e7 PMCID:PMC9197998

[59] Lakins MA,Munir H,Shields JD.Cancer-associated fibroblasts induce antigen-specific deletion of CD8⁺ T Cells to protect tumour cells.Nat Commun2018;9:948 PMCID:PMC5838096

[60] Huang TX,Huang HS.Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity.Gut2022;71:333-44 PMCID:PMC8762012

[61] MacGregor HL,Elia A.High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.J Immunother Cancer2019;7:357 PMCID:PMC6937725

[62] Yearley JH,Yu N.PD-L2 expression in human tumors: relevance to anti-PD-1 therapy in cancer.Clin Cancer Res2017;23:3158-67

[63] Chan LC,Xia W.IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.J Clin Invest2019;129:3324-38 PMCID:PMC6668668

[64] Li Z,Zhang J,Wang H.Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.Int J Cancer2019;145:1946-57 PMCID:PMC6767568

[65] Jiang Y,Lu X,Chen J.Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.Mol Immunol2021;140:47-58

[66] Gorchs L,Bankhead P.Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4⁺ and CD8⁺ T-cells.Front Immunol2019;10:847 PMCID:PMC6491453

[67] Hou A,Huang Q,Chen W.Targeting myeloid-derived suppressor cell, a promising strategy to overcome resistance to immune checkpoint inhibitors.Front Immunol2020;11:783 PMCID:PMC7249937

[68] Xiang X,Lu D.Targeting tumor-associated macrophages to synergize tumor immunotherapy.Signal Transduct Target Ther2021;6:75 PMCID:PMC7900181

[69] Li T,Zhu W.Targeting MDSC for immune-checkpoint blockade in cancer immunotherapy: current progress and new prospects.Clin Med Insights Oncol2021;15:11795549211035540 PMCID:PMC8365012

[70] Koikawa K,Suizu F.Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.Cell2021;184:4753-4771.e27 PMCID:PMC8557351

[71] Zhu Y,Meyer MA.CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.Cancer Res2014;74:5057-69 PMCID:PMC4182950

[72] Kumar V,Marvel D.Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors.Cancer Cell2017;32:654-668.e5 PMCID:PMC5827952

[73] Kieffer Y,Gentric G.Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.Cancer Discov2020;10:1330-51

[74] Francescone R,Franco-Barraza J.Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression.Cancer Discov2021;11:446-79 PMCID:PMC7858242

[75] Lin Y,Chen Y.CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.Hepatology2022;75:28-42

[76] Catenacci DV,Karrison T.Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer.J Clin Oncol2015;33:4284-92 PMCID:PMC4678179

[77] Ramanathan RK,Philip PA.Phase IB/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313.J Clin Oncol2019;37:1062-9 PMCID:PMC6494359

[78] Cutsem E, Tempero MA, Sigal D, et al; HALO 109-301 Investigators. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma.J Clin Oncol2020;38:3185-94 PMCID:PMC7499614

[79] Froeling FE,Chelala C.Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.Gastroenterology2011;141:1486-97, 1497.e1

[80] Sherman MH,Engle DD.Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.Cell2014;159:80-93 PMCID:PMC4177038

[81] Johnson DE,Grandis JR.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.Nat Rev Clin Oncol2018;15:234-48 PMCID:PMC5858971

[82] US National Library of Medicine. ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/show/NCT02699606 [Last accessed on 19 Aug 2022]

[83] Chauhan VP,Liu H.Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.Nat Commun2013;4:2516 PMCID:PMC3806395

[84] Zhou Y,Zhou X.Single-cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal cancer.Cancer Cell2020;38:818-828.e5

[85] Lambrechts D,Boeckx B.Phenotype molding of stromal cells in the lung tumor microenvironment.Nat Med2018;24:1277-89

[86] Bartoschek M,Bocci M.Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing.Nat Commun2018;9:5150 PMCID:PMC6279758

[87] Puram SV,Parikh AS.Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer.Cell2017;171:1611-1624.e24 PMCID:PMC5878932

[88] Li H,Sengupta D.Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors.Nat Genet2017;49:708-18

[89] Quante M,Tomita H.Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.Cancer Cell2011;19:257-72 PMCID:PMC3060401

[90] Costea DE,Osman AH.Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.Cancer Res2013;73:3888-901

[91] Hosein AN,Wang Z.Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.JCI Insight2019;5:129212 PMCID:PMC6777805

[92] Dominguez CX,Keerthivasan S.Single-cell RNA sequencing reveals stromal evolution into LRRC15⁺ myofibroblasts as a determinant of patient response to cancer immunotherapy.Cancer Discov2020;10:232-53

[93] Wang Y,Xu H.Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response.Cell Discov2021;7:36 PMCID:PMC8149399

[94] Patel AK,Thatikonda V.A subtype of cancer-associated fibroblasts with lower expression of alpha-smooth muscle actin suppresses stemness through BMP4 in oral carcinoma.Oncogenesis2018;7:78 PMCID:PMC6172238

[95] Gerling M,Kirn LM.Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth..Nat Commun2016;7:12321 PMCID:PMC4980446

[96] Shin K,Zhao C.Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors.Cancer Cell2014;26:521-33 PMCID:PMC4326077

[97] Pallangyo CK,Greten FR.IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.J Exp Med2015;212:2253-66 PMCID:PMC4689166

[98] Mizutani Y,Iida T.Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.Cancer Res2019;79:5367-81